Metastatic Cancer Lung: Clinical Trials

2 trials for Metastatic Cancer Lung, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Withdrawn 1

Follow Metastatic Cancer Lung: new trials by email Literature Review of Metastatic Cancer Lung trials Research Report on Metastatic Cancer Lung

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures
Atezolizumab 1200 mg IV, Tiragolumab 600 mg IV - Metastatic Cancer Lung, Advanced Lung Cancer
Phase 2WithdrawnGustave Roussy, Cancer Campus, Grand Paris2025-01-302026-03-23
[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging
[18F]-AzaFol, folarell - Metastatic Cancer Lung, Metastatic Ovarian Cancer
Phase 1CompletedUniversity of Lausanne Hospitals152017-04-012020-02-28

Narrower conditions

Lung Neoplasms (2)  ·  Ovarian Neoplasms (1)

Broader conditions

Lung Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Thoracic Neoplasms (2)  ·  Adnexal Diseases (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Gonadal Disorders (1)

Interventions

Folic Acid (1)  ·  Tiragolumab (1)  ·  atezolizumab (1)

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  University of Lausanne Hospitals (1)

Countries

Switzerland (1)

Top investigators

John Prior, Prof (1)

Results publications

PMID 32270313

NIH funding

2023 (1)